MEANS FOR INHIBITING PROTEINKINASE 3 EXPRESSION

FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to the field of molecular biology, genetic engineering and medicine.EFFECT: claimed is a molecule of ribonucleic acid, mediating the RNA interference, aimed against PKN3, as well as a lipocomplex, containing thereof, a pharmaceutical compos...

Full description

Saved in:
Bibliographic Details
Main Authors ZANTEL', ANSGAR, KAJL', OLIVER, KAUFMANN, JORG
Format Patent
LanguageEnglish
Russian
Published 20.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to the field of molecular biology, genetic engineering and medicine.EFFECT: claimed is a molecule of ribonucleic acid, mediating the RNA interference, aimed against PKN3, as well as a lipocomplex, containing thereof, a pharmaceutical composition, application and method of treating cancer disease involving the PI3-kinase pathway.48 cl, 2 tbl, 17 dwg, 13 ex Изобретение относится к области молекулярной биологии, генетической инженерии и медицины. Предложена молекула рибонуклеиновой кислоты, опосредующая интерференцию РНК, нацеленной против PKN3, а также содержащий её липокомплекс, фармацевтическая композиция, применение и способ лечения ракового заболевания, в которое вовлечен путь PI3-киназы. 12 н. и 36 з.п. ф-лы, 2 табл., 17 ил., 13 пр.
AbstractList FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to the field of molecular biology, genetic engineering and medicine.EFFECT: claimed is a molecule of ribonucleic acid, mediating the RNA interference, aimed against PKN3, as well as a lipocomplex, containing thereof, a pharmaceutical composition, application and method of treating cancer disease involving the PI3-kinase pathway.48 cl, 2 tbl, 17 dwg, 13 ex Изобретение относится к области молекулярной биологии, генетической инженерии и медицины. Предложена молекула рибонуклеиновой кислоты, опосредующая интерференцию РНК, нацеленной против PKN3, а также содержащий её липокомплекс, фармацевтическая композиция, применение и способ лечения ракового заболевания, в которое вовлечен путь PI3-киназы. 12 н. и 36 з.п. ф-лы, 2 табл., 17 ил., 13 пр.
Author KAJL', OLIVER
ZANTEL', ANSGAR
KAUFMANN, JORG
Author_xml – fullname: ZANTEL', ANSGAR
– fullname: KAJL', OLIVER
– fullname: KAUFMANN, JORG
BookMark eNrjYmDJy89L5WTQ93V19AtWcPMPUvD08_B08gzx9HNXCAjyD3H19PP29HMMdlUwVnCNCAhyDQ729PfjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxQaFGpqbGpmaGzkbGRCgBALw-J5s
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate СРЕДСТВА ИНГИБИРОВАНИЯ ЭКСПРЕССИИ ПРОТЕИНКИНАЗЫ 3
ExternalDocumentID RU2553561C2
GroupedDBID EVB
ID FETCH-epo_espacenet_RU2553561C23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:45:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Russian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_RU2553561C23
Notes Application Number: RU20090106071
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150620&DB=EPODOC&CC=RU&NR=2553561C2
ParticipantIDs epo_espacenet_RU2553561C2
PublicationCentury 2000
PublicationDate 20150620
PublicationDateYYYYMMDD 2015-06-20
PublicationDate_xml – month: 06
  year: 2015
  text: 20150620
  day: 20
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies SAJLENS TERAP'JUTIKS AG
RelatedCompanies_xml – name: SAJLENS TERAP'JUTIKS AG
Score 2.9870925
Snippet FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to the field of molecular biology, genetic engineering and medicine.EFFECT: claimed is a molecule...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title MEANS FOR INHIBITING PROTEINKINASE 3 EXPRESSION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150620&DB=EPODOC&locale=&CC=RU&NR=2553561C2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPkVhryanII0iQbEyFpSVPJrSTdLPRSS5vi33d2SasXvS27sI-Bb2a_3XkAvFiMcYOXHElOzQYGd8QnoaoP0HIzx7RrZstA4SS1ornxXphFB1aHWBiZJ_RLJkdERC0R743U15ufR6xA-lbuhtUKuz5fw9wNlJYdi3R5mqoEnkunk2DiK77vZnMlzVy8Oet4VfBRW59geyTAQD88EZSy-W1Rwks4neJk6-YKOtt9D879Q-G1Hpwl7X83Nlvo7a5hmNBxOiNI2kicRrEX53H6RqbZJKdxihx8PKNEJ7SQIkUFeQMkpLkfDXDlxfGUi2x-3KN-C10k__UdEOaoZbkUVTQ1ZoxKu9Irs7Qcm3NLs3mp96H_5zT3_4w9wIUQl3B60tRH6Dbbff2E5rWpnqVgvgFOf3r6
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokb87MHsRlj2xXZYDNuKm2GDjGG4kY2uCRckMOK_72sz0IvemjZpX1_yPn59HwV4sRjjBs85gpySdQ3uiCChqnfRcjPHtEtmy0LhOLHCmfE-N-cNWB1qYWSf0C_ZHBElaonyXkl9vfl5xApkbuWuV6xw6vN1mLmBUqNj0S5PU5XAc-lkHIx9xffddKYkqYues46ugo_a-gQ97L4QBvrhiaKUzW-LMryA0wlutq4uobHdt6HlHz5ea8NZXMe7cViL3u4KejEdJFOCoI1ESRh5URYlb2SSjjMaJYjBB1NKdELnkqWoIK-BDGnmh108eXG85SKdHWnUb6CJ4L-8BcIcNc-X4hdNjRn93C70wswtx-bc0mye6x3o_LnN3T9rz9AKs3i0GCGJ93AuWCcSoDT1AZrVdl8-oqmtiifJpG8-AH3t
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MEANS+FOR+INHIBITING+PROTEINKINASE+3+EXPRESSION&rft.inventor=ZANTEL%27%2C+ANSGAR&rft.inventor=KAJL%27%2C+OLIVER&rft.inventor=KAUFMANN%2C+JORG&rft.date=2015-06-20&rft.externalDBID=C2&rft.externalDocID=RU2553561C2